Kairos Ventures backs this UCLA start-up, bringing new technology that pioneers value-based health care services for complex and costly diseases

August 3, 2017

LOS ANGELES, August 3, 2017 – DEAR Health Inc., a Los Angeles-based health tech startup, announced today the successful partnership with Kairos Ventures. DEAR Health provides a technology platform which uses advanced data analytics to drive disease-specific, coordinated care pathways with streamlined provider workflows, patient apps and organizational decision support. Fully integrated with day-to-day care, come various programs for mental support, personalized education, wellness and work productivity. Prototypes have demonstrated significant health outcome improvements and a systematic elimination of waste through a decline in medical procedures and unnecessary pharmacy costs.

“We saw an opportunity to position us in the nexus of the rapid rising number of meaningful health technologies,” said Daniel Hommes, DEAR Health’s co-founder and CEO. “The uniqueness of our technology is the incorporation of deep knowledge about complex care delivery, and using advanced health analytics to truly offer patient-centric, value-based care. Our approach and sole focus is enhancing patient experiences and improving health outcomes while increasingly lowering costs. We are very excited to partner with Kairos and benefit from their incredible technology expertise. Their investment will accelerate our roll out of our services to our first customers.”

 

About Kairos:
Kairos Ventures is investing in the world’s leading scientific discoveries and commercializing them into viable businesses as quickly as possible. Kairos invests early, often during the formative stages of a company, and works closely with the world’s leading scientists to commercialize their technologies. They make investments between $150,000 and $5 Million and strive to ensure that the founding team, who make the early sacrifices in pursuit of their venture, retain the majority of the ownership. In addition to providing early-stage capital, Kairos leverages their expertise and extensive network of professionals specializing in all disciplines required to build a successful company, including legal, finance, marketing, operations, business development and HR. What unites Kairos with the founders of our portfolio companies and the investors in their fund is the belief that world class scientists, backed by the right investors, can have a significant impact on the world. (www.kairosventures.com)